Found: 29
Select item for more details and to access through your institution.
Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease—authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Clinical trial: Combination allopurinol‐thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study).
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 4, p. 504, doi. 10.1111/apt.17831
- By:
- Publication type:
- Article
Editorial: delving into the natural history of Crohn's disease and the impact of medical therapy.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Editorial: does anti‐TNF "treatment persistence" always equate to "effective treatment"? Only objective disease assessments can answer the question.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 718, doi. 10.1111/apt.16506
- By:
- Publication type:
- Article
Letter: ustekinumab dose intensification for loss of response—should we re‐induce before shortening the dose interval?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 564, doi. 10.1111/apt.15883
- By:
- Publication type:
- Article
A virtual clinic increases anti‐TNF dose intensification success via a treat‐to‐target approach compared with standard outpatient care in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1342, doi. 10.1111/apt.15742
- By:
- Publication type:
- Article
Are All Symptoms in Patients in IBD Due to Occult Inflammation?
- Published in:
- 2010
- By:
- Publication type:
- Letter
Persistence of Second and Third-Line Biologics in Inflammatory Bowel Disease: A Multi-Centre Cohort Study.
- Published in:
- Future Pharmacology, 2022, v. 2, n. 4, p. 669, doi. 10.3390/futurepharmacol2040041
- By:
- Publication type:
- Article
Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn's Disease.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 10, p. 2533, doi. 10.3390/diagnostics12102533
- By:
- Publication type:
- Article
Utility of panenteric capsule endoscopy for the detection of small‐bowel Crohn's disease in patients with a normal magnetic resonance enterography: A prospective observational pilot study.
- Published in:
- JGH Open, 2023, v. 7, n. 12, p. 966, doi. 10.1002/jgh3.13013
- By:
- Publication type:
- Article
Characterization of ulcerative colitis‐associated constipation syndrome (proximal constipation).
- Published in:
- JGH Open, 2018, v. 2, n. 5, p. 217, doi. 10.1002/jgh3.12076
- By:
- Publication type:
- Article
Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of doses.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 5, p. 724, doi. 10.1111/jgh.16133
- By:
- Publication type:
- Article
Predicting response after infliximab salvage in acute severe ulcerative colitis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 7, p. 1347, doi. 10.1111/jgh.14072
- By:
- Publication type:
- Article
A comparison of long-term healthcare utilization and costs in patients with acute severe ulcerative colitis receiving infliximab versus early colectomy.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319825595
- By:
- Publication type:
- Article
A comparison of long-term healthcare utilization and costs in patients with acute severe ulcerative colitis receiving infliximab versus early colectomy.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319825595
- By:
- Publication type:
- Article
Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 4, p. 583, doi. 10.1093/ecco-jcc/jjaa194
- By:
- Publication type:
- Article
Medical Management of Infliximab Failure in Acute Severe Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 7, p. 1029, doi. 10.1093/ecco-jcc/jjaa006
- By:
- Publication type:
- Article
Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 3, p. 289, doi. 10.1093/ecco-jcc/jjx146
- By:
- Publication type:
- Article
Faecal calprotectin delivers on convenience, cost reduction and clinical decision‐making in inflammatory bowel disease: a real‐world cohort study.
- Published in:
- Internal Medicine Journal, 2019, v. 49, n. 1, p. 94, doi. 10.1111/imj.14027
- By:
- Publication type:
- Article
Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status.
- Published in:
- Journal of Gastroenterology & Hepatology, 2011, v. 26, n. 5, p. 916, doi. 10.1111/j.1440-1746.2011.06624.x
- By:
- Publication type:
- Article
Adverse clinical phenotype in inflammatory bowel disease: A cross sectional study identifying factors potentially amenable to change.
- Published in:
- Journal of Gastroenterology & Hepatology, 2010, v. 25, n. 7, p. 1250, doi. 10.1111/j.1440-1746.2010.06302.x
- By:
- Publication type:
- Article
Gastrointestinal: Acute haemorrhage from a Dieulafoy lesion within a gastric diverticulum managed endoscopically.
- Published in:
- 2009
- By:
- Publication type:
- Other
Assessing quality of magnetic resonance enterography and its impact on disease assessment of ileal Crohn's disease.
- Published in:
- Intestinal Research, 2024, v. 22, n. 2, p. 152, doi. 10.5217/ir.2023.00095
- By:
- Publication type:
- Article
Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)- lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy.
- Published in:
- Intestinal Research, 2022, v. 20, n. 1, p. 101, doi. 10.5217/ir.2020.00146
- By:
- Publication type:
- Article
The synergy of dual faecal immunochemical and faecal calprotectin testing for accurate assessment of endoscopic and histological activity in inflammatory bowel disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2024, p. 1, doi. 10.1177/17562848241237895
- By:
- Publication type:
- Article
The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn's Disease: A Systematic Review and Meta-Analysis.
- Published in:
- Biomedicines, 2023, v. 11, n. 5, p. 1408, doi. 10.3390/biomedicines11051408
- By:
- Publication type:
- Article
Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Intestinal Ultrasound in the Assessment of Luminal Crohn's Disease.
- Published in:
- Gastrointestinal Disorders, 2022, v. 4, n. 4, p. 249, doi. 10.3390/gidisord4040024
- By:
- Publication type:
- Article